Drug Trial Radar · NCT07081958
A Study Evaluating the Effect of Daily Oral Tifeglipron (RO7795081) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
352
Actual
Start
Jul 29, 2025
Primary completion
Apr 28, 2026
Study completion Jul 30, 2026
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Jul 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and safety of tifeglipron (RO7795081) for chronic weight management in adult participants with obesity or overweight with at least one weight-related comorbidity, but without diabetes mellitus.
Conditions
- Obesity or Overweight
Interventions
TifeglipronDrug
Tifeglipron will be administered orally once daily, according to the randomized dosing regimen, during the 38-week treatment period.
PlaceboDrug
Placebo matching each tifeglipron dosing regimen arm will be administered orally once daily during the 38-week treatment period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Body Weight From Baseline to Week 30Time frame: Baseline to Week 30
Locations
36 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group
Anniston, Alabama
Orange County Research Center
Lake Forest, California
Prospective Research Innovations Inc.
Rancho Cucamonga, California
Asclepes Research Centers
Sherman Oaks, California
Encompass Clinical Research
Spring Valley, California
Chase Medical Research
Waterbury, Connecticut
Emerson Clinical Research Institute LLC
Washington D.C., District of Columbia
K2 Medical Research-Winter Garden
Clermont, Florida
K2 Medical Research-Maitland
Maitland, Florida
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia
Accellacare of Duly Health and Care
Oak Lawn, Illinois
Accellacare of McFarland
Ames, Iowa
Mercury Street Medical Group, PLLC
Butte, Montana
Neurobehavioral Research, Inc.
Cedarhurst, New York
Accellacare of Cary - Cary Medical Group
Cary, North Carolina
Accellacare - Hickory
Hickory, North Carolina
Accellacare of Raleigh
Raleigh, North Carolina
Accellacare of Rocky Mount
Rocky Mount, North Carolina
Accellacare of Salisbury
Salisbury, North Carolina
Accellacare of Piedmont Healthcare
Statesville, North Carolina
Accellacare of Wilmington, LLC
Wilmington, North Carolina
Accellacare Research of Winston Salem
Winston-Salem, North Carolina
Alliance for Multispecialty Research, LLC (AMR Norman)
Norman, Oklahoma
Tristar Clinical Investigations
Philadelphia, Pennsylvania
Internal Medicine and Pediatrics Associates of Bristol
Bristol, Tennessee
Alliance for Multispecialty Research. LLC
Knoxville, Tennessee
Accellacare of Knoxville
Knoxville, Tennessee
Knoxville-Summit-Halls Family Practice
Knoxville, Tennessee
Clinical Research Associates
Nashville, Tennessee
Texas Diabetes & Endocrinology, P.A.
Austin, Texas
Apex Mobile Clinical Research
Bellaire, Texas
Velocity Clinical Research
Dallas, Texas
Juno Research, LLC
Houston, Texas
Consano Clinical Research
Shavano Park, Texas
Chrysalis Clinical Research
St. George, Utah
Manassas Clinical Research Center
Manassas, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.